3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Glioblastoma
5
Carcinoma, Non-Small-Cell Lung
5
Squamous Cell Carcinoma of Head and Neck
4
Rectal Neoplasms
4
Neoplasms
4
Head and Neck Neoplasms
4
Colorectal Neoplasms
4
Stomach Neoplasms
3
Glioma
3
Esophageal Neoplasms
3
Carcinoma, Hepatocellular
3
Breast Neoplasms
3
Brain Neoplasms
3
Astrocytoma
3
Sarcoma
2
Pancreatic Neoplasms
2
Osteosarcoma
2
Lung Neoplasms
2
Carcinoma, Squamous Cell
2
Wilms Tumor
1
Urinary Bladder Neoplasms
1
Skin Neoplasms
1
Sinonasal Squamous Cell Carcinoma
1
Rhabdomyosarcoma
1
Recurrence
1
Radiation Injuries
1
Prostatic Neoplasms
1
Prostate Adenocarcinoma
1
Postoperative Complications
1
Pilonidal Sinus
1
Interventions
Specimen Handling
4
Radiotherapy
4
Radiation
4
Nivolumab
4
pembrolizumab
3
Magnetic Resonance Spectroscopy
3
Ipilimumab
3
Doxorubicin
3
CTLA-4 Antigen
3
Biopsy
3
talimogene laherparepvec
1
peposertib
1
pazopanib
1
liposomal doxorubicin
1
fludarabine
1
cabozantinib
1
aldesleukin
1
X-Rays
1
Trabectedin
1
Ifosfamide
1
Histamine H2 Antagonists
1
Famotidine
1
Dactinomycin
1
Cyclophosphamide
1
BO-112
1
Angptl4 protein, mouse
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Histiocytoma, Malignant Fibrous
×
Surgical Procedures, Operative
×
90 days
×
Clear all
No trials found.